Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus
Background: Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of reactive metabolites and antioxidants, such as glutathione, glutathione peroxidase, superoxide dismutase and catalase in type 2 di...
Saved in:
Published in: | British journal of biomedical science Vol. 76; no. 4; pp. 166 - 171 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Taylor & Francis
02-10-2019
Taylor & Francis Ltd |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of reactive metabolites and antioxidants, such as glutathione, glutathione peroxidase, superoxide dismutase and catalase in type 2 diabetes mellitus (T2DM) provides an opportunity for identifying gene variants and risk genotypes. We hypothesised that certain antioxidant gene-gene interactions are linked with T2DM and can model disease risk prediction.
Materials and methods: Genotyping of single nucleotide polymorphisms (SNPs) in antioxidant genes for glutathione (GST), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) was performed in 558 T2DMs and 410 age and sex matched healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), routine lab indices by standard techniques.
Results: The null/null allele combination of GSTM1del and GSTT1del increased disease risk up to 1.7-fold. The combination of SNPs in GSTM1del, GSTT1del, GSTP1 + 313A/G and in CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T increased the risk of diabetes 13.5 and 2.1-fold, respectively. Interaction of SNPs GSTM1del, GSTT1del, GSTP1 + 313A/G (105Ile/Val), CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T were significantly linked with disease risk >5 × 10
3
fold.
Conclusion: As the number of gene combinations increase, there is a rise in the odds ratio of disease risk, suggesting that gene-gene interaction plays an important role in T2DM susceptibility. Individuals who possess the GSTM1del, GSTT1del, GSTP1 105I/V(+313A/G), CAT-21A/T, SOD2 + 47C/T and GPx1 + 599C/T are at very high risk of developing T2DM. |
---|---|
AbstractList | Background: Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of reactive metabolites and antioxidants, such as glutathione, glutathione peroxidase, superoxide dismutase and catalase in type 2 diabetes mellitus (T2DM) provides an opportunity for identifying gene variants and risk genotypes. We hypothesised that certain antioxidant gene-gene interactions are linked with T2DM and can model disease risk prediction.Materials and methods: Genotyping of single nucleotide polymorphisms (SNPs) in antioxidant genes for glutathione (GST), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) was performed in 558 T2DMs and 410 age and sex matched healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), routine lab indices by standard techniques.Results: The null/null allele combination of GSTM1del and GSTT1del increased disease risk up to 1.7-fold. The combination of SNPs in GSTM1del, GSTT1del, GSTP1 + 313A/G and in CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T increased the risk of diabetes 13.5 and 2.1-fold, respectively. Interaction of SNPs GSTM1del, GSTT1del, GSTP1 + 313A/G (105Ile/Val), CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T were significantly linked with disease risk >5 × 103 fold.Conclusion: As the number of gene combinations increase, there is a rise in the odds ratio of disease risk, suggesting that gene-gene interaction plays an important role in T2DM susceptibility. Individuals who possess the GSTM1del, GSTT1del, GSTP1 105I/V(+313A/G), CAT-21A/T, SOD2 + 47C/T and GPx1 + 599C/T are at very high risk of developing T2DM. Background: Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of reactive metabolites and antioxidants, such as glutathione, glutathione peroxidase, superoxide dismutase and catalase in type 2 diabetes mellitus (T2DM) provides an opportunity for identifying gene variants and risk genotypes. We hypothesised that certain antioxidant gene-gene interactions are linked with T2DM and can model disease risk prediction. Materials and methods: Genotyping of single nucleotide polymorphisms (SNPs) in antioxidant genes for glutathione (GST), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) was performed in 558 T2DMs and 410 age and sex matched healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), routine lab indices by standard techniques. Results: The null/null allele combination of GSTM1del and GSTT1del increased disease risk up to 1.7-fold. The combination of SNPs in GSTM1del, GSTT1del, GSTP1 + 313A/G and in CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T increased the risk of diabetes 13.5 and 2.1-fold, respectively. Interaction of SNPs GSTM1del, GSTT1del, GSTP1 + 313A/G (105Ile/Val), CAT-21A/T, SOD2 + 47C/T, GPx1 + 599C/T were significantly linked with disease risk >5 × 10 3 fold. Conclusion: As the number of gene combinations increase, there is a rise in the odds ratio of disease risk, suggesting that gene-gene interaction plays an important role in T2DM susceptibility. Individuals who possess the GSTM1del, GSTT1del, GSTP1 105I/V(+313A/G), CAT-21A/T, SOD2 + 47C/T and GPx1 + 599C/T are at very high risk of developing T2DM. : Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of reactive metabolites and antioxidants, such as glutathione, glutathione peroxidase, superoxide dismutase and catalase in type 2 diabetes mellitus (T2DM) provides an opportunity for identifying gene variants and risk genotypes. We hypothesised that certain antioxidant gene-gene interactions are linked with T2DM and can model disease risk prediction. : Genotyping of single nucleotide polymorphisms (SNPs) in antioxidant genes for glutathione ( ), glutathione peroxidase ( ), superoxide dismutase ( ) and catalase (CAT) was performed in 558 T2DMs and 410 age and sex matched healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), routine lab indices by standard techniques. : The null/null allele combination of del and del increased disease risk up to 1.7-fold. The combination of SNPs in del, del, + 313A/G and in -21A/T, + 47C/T, + 599C/T increased the risk of diabetes 13.5 and 2.1-fold, respectively. Interaction of SNPs del, del, + 313A/G (105Ile/Val), -21A/T, + 47C/T, + 599C/T were significantly linked with disease risk >5 × 10 fold. : As the number of gene combinations increase, there is a rise in the odds ratio of disease risk, suggesting that gene-gene interaction plays an important role in T2DM susceptibility. Individuals who possess the del, del, 105I/V(+313A/G), -21A/T, + 47C/T and + 599C/T are at very high risk of developing T2DM. |
Author | Srivastava, N Banerjee, M Vats, P Kushwah, AS |
Author_xml | – sequence: 1 givenname: M surname: Banerjee fullname: Banerjee, M email: mhglucknow@rediffmail.com organization: Molecular & Human Genetics Laboratory, Department of Zoology, University of Lucknow – sequence: 2 givenname: P surname: Vats fullname: Vats, P organization: Molecular & Human Genetics Laboratory, Department of Zoology, University of Lucknow – sequence: 3 givenname: AS surname: Kushwah fullname: Kushwah, AS organization: Department of Zoology, Institute of Science, Banaras Hindu University – sequence: 4 givenname: N surname: Srivastava fullname: Srivastava, N organization: Department of Physiology, King George's Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30900957$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtv1DAURi1URKeFnwCyxIZNBj8TeweqeFSqxAbE0nLia-QqsQfbgc6_x9FMWbBgdW195z50rtBFTBEQeknJnhJF3hLdD0IJuWeE6j2VWqpeP0E7JgbREaX7C7TbmG6DLtFVKfekkWzon6FLTjQhWg479P02Vsh2qiFFnDy2sb0egmsV_4AI-JfNoX1KSxwua5ngUMMY5lCPuCZcjwfADLtgR6hQ8AJzi9byHD31di7w4lyv0bePH77efO7uvny6vXl_101ci9q5fvRSW00VHydpheYTEWQYiXcAUgk1auIkl1yBBeYn6XvOnWLaadYCwq_Rm9PcQ04_VyjVLKHdOM82QlqLYVT3kg1KbOjrf9D7tObYrjOMU0oFJ4Q3Sp6oKadSMnhzyGGx-WgoMZt582jebObN2Xzre3Wevo4LuL9dj6ob8O4EhOhTXuzvlGdnqj3OKfts4xSK4f_f8QcTjJRP |
CitedBy_id | crossref_primary_10_3390_ijerph20021520 crossref_primary_10_2147_DMSO_S300525 crossref_primary_10_2174_1875692120666221124121316 crossref_primary_10_1080_09674845_2019_1692455 crossref_primary_10_1016_j_neuint_2023_105490 crossref_primary_10_3390_antiox12061280 crossref_primary_10_1016_j_taap_2022_116057 crossref_primary_10_3390_antiox11061188 crossref_primary_10_1007_s00592_024_02309_x crossref_primary_10_1080_09674845_2019_1660501 crossref_primary_10_2174_1573399816999201012201111 crossref_primary_10_1136_bmjdrc_2020_001773 crossref_primary_10_3389_fgene_2022_1015879 crossref_primary_10_47470_0869_7922_2023_31_2_83_88 crossref_primary_10_1002_gepi_22350 |
Cites_doi | 10.1089/dia.2012.0326 10.1080/09674845.2018.1482734 10.4239/wjd.v6.i6.850 10.4103/0019-5359.42021 10.1016/j.ymgme.2010.12.012 10.1016/j.nut.2016.07.018 10.1016/j.metabol.2006.08.011 10.5455/dmm.20131027101207 10.1007/s10528-012-9499-z 10.1038/sj.cr.7290272 10.1007/s11033-013-2739-4 10.1016/S0140-6736(16)31679-8 10.1161/CIRCRESAHA.115.306825 10.4103/0022-3859.68633 10.1016/j.ijdm.2010.08.002 10.1186/1471-2350-14-110 10.1097/GIM.0b013e31812eece0 10.1007/s100380300021 10.1007/s10528-015-9675-z 10.3109/10715762.2014.971782 10.1186/1471-2350-2-4 10.1089/gtmb.2014.0265 |
ContentType | Journal Article |
Copyright | 2019 British Journal of Biomedical Science 2019 2019 British Journal of Biomedical Science |
Copyright_xml | – notice: 2019 British Journal of Biomedical Science 2019 – notice: 2019 British Journal of Biomedical Science |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 4T- K9. NAPCQ 7X8 |
DOI | 10.1080/09674845.2019.1595869 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Docstoc ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Docstoc MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2474-0896 |
EndPage | 171 |
ExternalDocumentID | 10_1080_09674845_2019_1595869 30900957 1595869 |
Genre | Articles Journal Article |
GrantInformation_xml | – fundername: University Grants Commission funderid: 10.13039/501100001501 |
GroupedDBID | --- 0R~ 23N 5GY 5RE 6J9 7RV 8AO 8R4 8R5 AAJNR AALUX ABBKH ABEIZ ABQIS ABUPF ACENM ACGFO ACGFS ACGOD ACPRK ADCVX ADFCX ADFRT AECIN AENEX AHMBA AIJEM AIRBT ALMA_UNASSIGNED_HOLDINGS ALQZU ARJSQ BABNJ BENPR BHPHI BLEHA BOHLJ CCCUG EBS EMOBN EX3 F5P GROUPED_DOAJ H13 HCIFZ KYCEM LJTGL M4Z M7P OK1 P2P Q2X RWL RXW SJN TAE TAF TFL TFW U5U UHWXJ UNMZH WOW WX9 X6Y .GJ 3O- 3V. 53G 7X7 88E 88I 8AF 8C1 8FE 8FH 8FI 8FJ 9T4 AAFWJ AAKQS ABJNI ABUWG ACKZS ADBBV ADFZZ AFKRA AFPKN AGYJP ALIPV AZQEC BBNVY BKEYQ BPHCQ BVXVI C1A CCPQU CGR CUY CVF CZDIS DRXRE DWQXO DWTOO ECM EHMNL EIF EJD FYUFA GNUQQ HMCUK LK8 M1P M2P M2Q NAPCQ NPM O9- OHT PGMZT PQQKQ PROAC PSQYO RPM S0X TDBHL UKHRP ZXP AAYXX CITATION 4T- K9. 7X8 |
ID | FETCH-LOGICAL-c394t-d6bf59a9183bc5a493c0407b0fdee5848b90d53538eae2fc5f633d829d920d503 |
ISSN | 0967-4845 |
IngestDate | Fri Oct 25 00:35:01 EDT 2024 Thu Oct 10 16:04:17 EDT 2024 Thu Sep 12 17:44:59 EDT 2024 Sat Sep 28 08:29:05 EDT 2024 Tue Jul 04 18:26:50 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | susceptibility Type 2 diabetes mellitus gene-gene interaction antioxidants gene variants |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c394t-d6bf59a9183bc5a493c0407b0fdee5848b90d53538eae2fc5f633d829d920d503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30900957 |
PQID | 2311143003 |
PQPubID | 4969 |
PageCount | 6 |
ParticipantIDs | crossref_primary_10_1080_09674845_2019_1595869 proquest_miscellaneous_2196527840 informaworld_taylorfrancis_310_1080_09674845_2019_1595869 pubmed_primary_30900957 proquest_journals_2311143003 |
PublicationCentury | 2000 |
PublicationDate | 2019-10-02 |
PublicationDateYYYYMMDD | 2019-10-02 |
PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | British journal of biomedical science |
PublicationTitleAlternate | Br J Biomed Sci |
PublicationYear | 2019 |
Publisher | Taylor & Francis Taylor & Francis Ltd |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd |
References | Moore DJ (CIT0002) 2009; 5 CIT0030 CIT0032 CIT0031 CIT0012 Saxena M (CIT0020) 2015; 7 Vats P (CIT0011) 2017; 4 CIT0013 CIT0016 CIT0015 Shi YY (CIT0006) 2005; 2005 CIT0018 CIT0001 CIT0022 Saxena M (CIT0008) 2017; 13 Saxena M (CIT0017) 2012; 3 Gautam S (CIT0023) 2013; 13 Saxena M (CIT0019) 2014; 140 CIT0003 Gautam S (CIT0021) 2011; 134 CIT0025 Verma S (CIT0014) 2013; 2 CIT0024 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 Negi G (CIT0010) 2011; 2 CIT0028 CIT0009 |
References_xml | – ident: CIT0025 doi: 10.1089/dia.2012.0326 – ident: CIT0012 doi: 10.1080/09674845.2018.1482734 – ident: CIT0001 doi: 10.4239/wjd.v6.i6.850 – ident: CIT0015 doi: 10.4103/0019-5359.42021 – ident: CIT0024 doi: 10.1016/j.ymgme.2010.12.012 – volume: 5 start-page: 1015 year: 2009 ident: CIT0002 publication-title: Vasc Health Risk Manag contributor: fullname: Moore DJ – ident: CIT0026 doi: 10.1016/j.nut.2016.07.018 – ident: CIT0032 doi: 10.1016/j.metabol.2006.08.011 – ident: CIT0013 doi: 10.5455/dmm.20131027101207 – volume: 13 start-page: 439 year: 2013 ident: CIT0023 publication-title: Indian J Med Sci contributor: fullname: Gautam S – ident: CIT0016 doi: 10.1007/s10528-012-9499-z – volume: 2005 start-page: 97 year: 2005 ident: CIT0006 publication-title: Cell Res doi: 10.1038/sj.cr.7290272 contributor: fullname: Shi YY – ident: CIT0018 doi: 10.1007/s11033-013-2739-4 – ident: CIT0003 doi: 10.1016/S0140-6736(16)31679-8 – ident: CIT0009 doi: 10.1161/CIRCRESAHA.115.306825 – volume: 134 start-page: 107 year: 2011 ident: CIT0021 publication-title: Indian J Med Res contributor: fullname: Gautam S – ident: CIT0028 doi: 10.4103/0022-3859.68633 – volume: 2 start-page: 71 year: 2011 ident: CIT0010 publication-title: Inst Integr Omics Appl Biotechnol J contributor: fullname: Negi G – volume: 4 start-page: 290 year: 2017 ident: CIT0011 publication-title: Eur J Biomed Pharm Sci contributor: fullname: Vats P – ident: CIT0022 doi: 10.1016/j.ijdm.2010.08.002 – volume: 13 start-page: 1 year: 2017 ident: CIT0008 publication-title: Curr Diabetes Rev contributor: fullname: Saxena M – ident: CIT0031 doi: 10.1186/1471-2350-14-110 – ident: CIT0027 doi: 10.1097/GIM.0b013e31812eece0 – ident: CIT0030 doi: 10.1007/s100380300021 – volume: 7 start-page: 560 year: 2015 ident: CIT0020 publication-title: J Chem Pharm Res contributor: fullname: Saxena M – volume: 2 start-page: 685 year: 2013 ident: CIT0014 publication-title: Int J Bioassays contributor: fullname: Verma S – ident: CIT0004 doi: 10.1007/s10528-015-9675-z – ident: CIT0005 doi: 10.3109/10715762.2014.971782 – ident: CIT0029 doi: 10.1186/1471-2350-2-4 – volume: 140 start-page: 77 year: 2014 ident: CIT0019 publication-title: Indian J Med Res contributor: fullname: Saxena M – ident: CIT0007 doi: 10.1089/gtmb.2014.0265 – volume: 3 start-page: 3015 year: 2012 ident: CIT0017 publication-title: Ann Biol Res contributor: fullname: Saxena M |
SSID | ssj0019276 |
Score | 2.320118 |
Snippet | Background: Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045.... : Diabetes is the seventh most common disease leading to death with a global estimate of 425 million diabetics, expected to be 629 million in 2045. The role of... |
SourceID | proquest crossref pubmed informaworld |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 166 |
SubjectTerms | Adult Aged Alleles Antioxidants Case-Control Studies Catalase Catalase - genetics Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - genetics Diabetes Mellitus, Type 2 - physiopathology Epistasis, Genetic Female Gene Frequency Gene polymorphism gene variants gene-gene interaction Genetic Predisposition to Disease Genotyping Glutathione peroxidase Glutathione Peroxidase - genetics Glutathione transferase Glutathione Transferase - genetics Humans Male Metabolites Middle Aged Polymerase chain reaction Polymorphism, Restriction Fragment Length Prognosis Restriction fragment length polymorphism Risk Single-nucleotide polymorphism Superoxide dismutase Superoxide Dismutase - genetics susceptibility Type 2 diabetes mellitus |
Title | Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus |
URI | https://www.tandfonline.com/doi/abs/10.1080/09674845.2019.1595869 https://www.ncbi.nlm.nih.gov/pubmed/30900957 https://www.proquest.com/docview/2311143003 https://search.proquest.com/docview/2196527840 |
Volume | 76 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLY6g4S4IHYKAzISN5QqixPbR5aiEYi5tCy3yI5tMSPRoiYp_Hyel2wdECDEJa3sNrH8vvgtfn4fQk8VjZlh0kQV6JqIUJlEnKUmUpUUzCSVku5Q2OmKnn1ir5ZkOZt1XIBD23-VNLSBrO3J2b-Qdn9TaIDvIHO4gtTh-kdydyG-QABu9_htNuP3cwWfli1ZP9uDc-xyX1zEvK1dWovLkPV26EFI9ost2NmE6MBBIaRR1Ql_in84Yjng5YXY6N2F1pPI6wfR1JPDZW_b-vM34UI8AzPyane-F2C97sWwZxQCFAl3qW6DO7u-xBUyDkLaquvMF5RcaNeWEkqimHme226N9hwxAYtktOAmRTHS3Ymnc7mkFkIeJbfMKiS3CX18AXZczjxNzEHF7dBzhK6ksHrZxXP15qzfmuKpYyzsh94dC7MF23_2gInBMymH-2unxhk36xvoevBK8HMPp5topje30NV3Ie_iNvo4QhXeGjxCFbaowh2qoEfhKapws8UWVTjFHapwh6o76P3r5frlaRQoOaIq46SJVCFNzgUHRSCrXBCeVaAFqIyN0hpsWSZ5rPIMtKgWOjVVboosUyzliqfQEWd30fFmu9H3EU6UpmAPGyqIIhTul7CYyUKLTHFDSTpHi27eyq--8kqZdAVtw0SXdqLLMNFzxMezWzYOeMZjrsx-89-TThRleHnqElyfBNwJ0Htz9KTvhuXX7qnBy7Nt4Te2IqfdvI_n6J4XYT_aLObWg6EP_mFgD9G14Z06QcfNrtWP0FGt2scOlj8Ag8eudg |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+of+antioxidant+gene+variants+and+susceptibility+to+type+2+diabetes+mellitus&rft.jtitle=British+journal+of+biomedical+science&rft.au=Banerjee%2C+M&rft.au=Vats%2C+P&rft.au=Kushwah%2C+AS&rft.au=Srivastava%2C+N&rft.date=2019-10-02&rft.pub=Taylor+%26+Francis&rft.issn=0967-4845&rft.eissn=2474-0896&rft.volume=76&rft.issue=4&rft.spage=166&rft.epage=171&rft_id=info:doi/10.1080%2F09674845.2019.1595869&rft.externalDocID=1595869 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0967-4845&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0967-4845&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0967-4845&client=summon |